{"id":4881,"date":"2025-11-06T23:20:16","date_gmt":"2025-11-06T20:20:16","guid":{"rendered":"https:\/\/medova.com.tr\/en\/?p=4881"},"modified":"2025-11-06T23:20:16","modified_gmt":"2025-11-06T20:20:16","slug":"prof-dr-mehmet-dagli_","status":"publish","type":"post","link":"https:\/\/medova.com.tr\/en\/prof-dr-mehmet-dagli_\/","title":{"rendered":"Prof. Dr. Mehmet Da\u011fl\u0131"},"content":{"rendered":"

[vc_row][vc_column width=”3\/12″][vc_single_image image=”4717″ alignment=”center”][vc_column_text css=”.vc_custom_1745998801189{margin-top: 15px !important;}”]<\/p>\n

Prof. Dr. Mehmet Da\u011fl\u0131<\/span><\/strong><\/span>
\nHematology<\/p>\n

[\/vc_column_text][\/vc_column][vc_column width=”6\/12″ el_class=”doktorcv”][vc_column_text]<\/p>\n

Hematology<\/h1>\n
EDUCATIONAL BACKGROUND\/FACULTY<\/span><\/h5>\n

Ataturk University Faculty of Medicine, Erzurum \/ 1983
\nAnkara Numune Education and Research Hospital 4th Internal Medicine Clinic \/ 1990
\nAnkara University Department of Internal Medicine Hematology Department and Ankara Numune Education and Research Hospital Hematology Clinic \/ 1993
\nSelcuk University Selcuklu Faculty of Medicine \/ 2012
\nSelcuk University Selcuklu Faculty of Medicine \/ 2017<\/p>\n

PROFESSIONAL INTEREST FIELDS<\/span><\/h5>\n

Anemia
\nLeukemia
\nApheresis
\nLymph Node Cancers
\nMultiple Myeloma
\nStem Cell Therapy
\nBlood Transfusion
\nHomeopathy
\nHematological Malignancies
\nBleeding Coagulation Disorder
\nBioresonance<\/p>\n

E-MAIL<\/span><\/h5>\n

mehmet.dagli@medova.com.tr<\/a><\/p>\n

SCIENTIFIC PUBLICATIONS<\/span><\/h5>\n

A- INTERNATIONAL STUDIES<\/strong><\/p>\n

A-1: Research articles published in international journals that are included in SCI, SCI-Expanded, SSCI, AHCI and have an Impact factor of 1.0 and above:<\/strong><\/p>\n

    \n
  • A-1.1. T.Demirer,M.Da\u011fl\u0131,O.\u0130lhan,M.Ayl\u0131,R.Haznedar; \u2018\u2019A Randomized Trial of Assessment of efficacy of Leukopheresis Volumes 8 Liters vs 12 Liters\u2019\u2019 Bone Marrow Transplantation; Impact Factor: 3.541 (2002) ,29:(29);893-887<\/li>\n
  • A-1.2. T.Demirer,M.Ayl\u0131,M.Da\u011fl\u0131, T.Fen. \u2018\u2019The effect of posttransplant spironolactone on daily potassium requirement in patients undergoing autologous stem-cell transplantation\u2019\u2019: Bone Marrow Transplantation. 2002 .30;703-706 Impact Factor: 3.541<\/li>\n
  • A-1.3. T. Demirer, M. Ayl\u0131, M.\u00d6zcan, N. G\u00fcnel, R.Haznedar, M.Da\u011fl\u0131, T.Fen Y.Gen\u00e7, S.Din\u00e7er, \u2018\u2019Mobilization of peripheral blood stem cell with chemotheraphy and recombinant human granulocyte colony-stimulating fact\u00f6r (RhG-CSF) ; a rondomized evaluation of different doses of rhG- CSF\u2019\u2019: British Journal of Haemotology Impact Factor:4.942 2002 116;468-474:<\/li>\n<\/ul>\n
      \n
    • A-1.4. T. Demirer, M.Ayl\u0131, M.Da\u011fl\u0131, R.Haznedar \u2018\u2019Influence of post -transplant recombinant human granulocyte colon \u2013stimulating factor administration on peritransplant morbidity in patients undergoing autologous stem cell transplantation\u2019\u2019 British Journal of Haemotology Impact Factor:4.942 2002.118;1104-1111;<\/li>\n
    • A-1.5. T.Demirer, O.Ilhan, M.Ayli, M.Arat M.Da\u011fl\u0131, M.Ozcan, R.Haznedar, Y.Genc, T.Fen, E.Ayyildiz,S.Dincer, \u2018\u2019 Monitoring of Peripheral Blood CD34+ Cell Counts on the First Day of Apheresis Is Highly Predictive for Efficient CD34+ Cell Yield.\u2019\u2019 Therapeutic Apheresis Impact Factor: 1.529, ;2002 Volume 6 Issue 5, Pages 384 \u2013 389<\/li>\n
    • A-1.6. T.Demirer, M. Ayl\u0131, O. \u0130lhan, M. Da\u011fl\u0131 . M.Arat.N.G\u00fcnel \u2018\u2019High dose thiotepe melphalan and carboplatin (TMCb) Fallowed by autologous stem cell transplation in patient wiht advanced breast cancer a retrospective evaluation \u2018\u2019 Bone Marrow Transplantation (2003) 31 ,755-761<\/li>\n
    • A-1.7. \u00d6.\u015eahin Bal\u00e7\u0131k, M.\u00d6zt\u00fcrk, M.Da\u011fl\u0131, O. Kaftan, A. Ko\u015far\u2019\u2019 \u0130ncreased eryhtropoetin levels in reactive thrombocytosis\u2019\u2019 Heamatologia; 2002 32(1):59-65 Impact Factor 5.935<\/li>\n
    • A-1.8: M.\u00d6zt\u00fcrk, N.\u015een\u011f\u00fcl, M.Da\u011fl\u0131, A.Ko\u015far \u2018\u2019Global fibrinolytic capacity in colorectal cancer: A.New Clue To Occult Fibrinolysis\u2019\u2019; Clinical App Thrombosis\/Hemostasis Impact Factor:1.016 ;9(1);T1-T4 2003<\/li>\n
    • A-1.9; D.Kaya, M.C. Ko\u00e7kar, N.Bavbek, M.Da\u011fl\u0131,A Ko\u015far \u2018\u2019Cardiac dysfunction in cirrhosis: . Hepatology research ;(2003) ;26:181-185 Impact Factor;1.562<\/li>\n
    • A-1.10; C. Ko\u00e7kar, O. Ko\u00e7kar, M. \u00d6zt\u00fcrk, M. Da\u011fl\u0131 , A. Ko\u015far \u2018\u2019 Golobal f\u0131br\u0131nolyt\u0131c capac\u0131ty \u0131ncreased exponent\u0131ally \u0131n metastat\u0131k colorectal cancer\u2019\u2019 Cl\u0131n\u0131cal and Appl\u0131ed Thrombos\u0131s-Hemostasis 2005 (11) 2:227-230 Impact Factor:1.016<\/li>\n
    • A-1.11M.Da\u011fl\u0131, \u0130.Saritas,\u2019\u2019 Using artificial neural network for the Prediction of Anemia seen in Beh\u00e7et Disease.” Energy Education Science and Technology Part A: (ISI) , 1085-1092 pp., 2012 \u0130mpact Fakt\u00f6r;2.31<\/li>\n
    • A-1.12; Korkmaz, H., Bugdaci, M.S., Temel, T., Dagli, M., Karabagli, P. \u2018\u2019Autoimmune hepatitis-primary biliary cirrhosis overlap syndrome concomitant with immune hemolytic anemia and immune thrombocytopenic purpura (Evans syndrome)\u2019\u2019 Clinics and Research in Hepatology and Gastroenterology 37 (2) PP. e45 -50 \u0130mpact fakt\u00f6r:2.547<\/li>\n<\/ul>\n

      INTERNATIONAL STUDIES AFTER ASSOCIATE PROFESSORSHIP<\/strong><\/p>\n

        \n
      • A-1.13 M.Dagli, S.Yilmaz, A.Sivrikaya, M.F.Demirci; Serum prohepcidin and hepcidin levels in patients with rheumatoid arthritis: a prospective study T\u00fcrkiye Klinikleri T\u0131p Dergisi (ISI)2013;33;4;18-21 ; \u0130mpact Fakt\u00f6r;1<\/li>\n
      • A-1.14 Da\u011fl\u0131.M,Y\u0131lmaz.Sivrikaya.A,\u00d6zt\u00fcrk.B; Serum Prohepcidin and Hepcidin levels in Patients with Ankylosing Spondyltis;A Prospective Study (2014) Journal of Clinical and Analytical Medicene JCAM ; Do\u0131;10.4328\/jcam2451<\/li>\n
      • A-1.15 L. Kutlucan, A. Kutlucan, B. Basaran, M. Dagl\u0131, A. Basturk. B. Kozanhan, M. G\u00fcr, E. Senocak, M. Kos. \u2018The predictive effect of initial complete blood count of intensive care unit patients on mortality, length of hospitalization, and nosocomial infections.\u2019 Eur Rev Med Pharmacol Sci. 2016;20:1467-1473.\u0130mpact Fakt\u00f6r:1.575<\/li>\n
      • A-1.16; M.Z. Ko\u00e7ak,M.Da\u011fl\u0131,A.\u00dcnl\u00fc;The ratio of platelet\/lymphocyte,the ratio of neutrophil\/Lymphocyte and some haemogram related to thrombosis in essential thrombocytosis and polycytemiaVera Biomedical Research ( 2017);28(7):3036-3039 \u0130mpakt Fakt\u00f6r.1.07<\/li>\n
      • A-1.17 M.Z. Ko\u00e7ak,M.Da\u011fl\u0131,A.\u00dcnl\u00fc; Clinical significance of beta 2 glycoprotein I Antibodies in Bcr Abl(-) myeloproliferative neoplams; Biomedical Research ( 2017);28(6):2826-2829<\/li>\n
      • A-1.18;M.Dagli,A.Kutlucan,S.Abusoglu,A.Basturk,M.Sozen,L.Kutlucan,A.Unlu,F. Y\u0131lmaz ; Evaluation of bone mineral density and parameters related to bone metabolism in hemophiliac patients ; Bosnian Journal of Basic Medical Sciences \u0130mpact Fakt\u00f6r:1.0<\/li>\n
      • A-2:SCI,SCI-Expanded,SSCI,AHCI,de yer alan ve Impact fakt\u00f6r\u00fc:0-0.9 olan uluslar aras\u0131 dergilerde yay\u0131mlanan ara\u015ft\u0131r ma makalesi:<\/li>\n
      • A-2.1; \u00d6. Atao\u011flu, T.Fen, \u00d6.S\u00fcer, M.Da\u011fl\u0131. \u2018\u2019Epstein-Bar Vir\u00fcs Latent Membrane Protein 1(LMP-1) ,in hodgkin!s Lymphoma Patient in T\u00fcrkey:\u2019\u2019 Turkish Journal of Hematology ; 2001:18(2):123-125 \u0130mpact Fakt\u00f6r:0.494<\/li>\n
      • A-2.2; M.Da\u011fl\u0131, T. Demirer, M. Ayl\u0131, R.Haznedar.\u2019\u2019 Plazmacytoma in the Bilateral breast cancer: Turkish Journal of Hematology ; 2002;19(4) 481-483<\/li>\n
      • A-2.3; : M. Da\u011fl\u0131 \u2018\u2019 Our Exper\u0131ence in hodgk\u0131n D\u0131sease\u2019\u2019 International Journal of Hematology and Oncology; 2002 -4(12)184-187 \u0130mpact Fakt\u00f6r:0.<\/li>\n
      • A-2.4; M.Da\u011fl\u0131,S.Y\u0131lmaz ,A.Sivrikaya,G.\u00c7elik;\u2019\u2019 The Role of Prohepc\u0131d\u0131n and Hepc\u0131d\u0131n \u0131n Anem\u0131a Assoc\u0131ated w\u0131th Behcet disease\u2019\u2019 International Journal of Hematology and Oncology (UHOD) (ISI) , 2012;2;22 ;94-98:\u2019<\/li>\n
      • A-2.5; Vatansev, H., \u00d6zt\u00fcrk, B., Yilmaz, S., Sivrikaya, A., Da\u01e7li, M., Kiyici, A., \u00dcnl\u00fc, A. \u2018\u2019Asymmetric dimethylarginine and arginine levels in patients with rheumatoid arthritis | Romatoid artritli hastalarda asimetrik dimetilarjinin ve arjinin d\u00fczeyleri\u2019\u2019 Turkish Journal of Biochemistry 38 (2) PP. 169 – 175 Impact fakt\u00f6r;0,703<\/li>\n
      • A-2.6; B.K.Ar\u0131ba\u015f,K.Arda,Z.Yolo\u011flu,S.\u00d6zdemir,M.Da\u011fl\u0131,\u2019\u2019 Imaging f\u0131ndings and clinical features of patients with multiple myeloma with the prognostic effect of bone marrow focal and diffuse infiltrationpatterns on spine MRI\u2019\u2019 M\u0131nerva Medica (ISI) , 115-124 pp., 2011 \u0131mpact fakt\u00f6r:0.771<\/li>\n
      • A-2,7; H.T.Dag\u0131,A.R.Ugur,M.Da\u011fl\u0131,\u0130.Tuncer;Campylobacter Fet\u00fcs Subsp.Fet\u00fcs Bacteremia in a patient with Myelodysplastic Syndrome ;A Case Report;Journal of Microbiology and \u0131nfectious Diseases;2014;4(4):165-167 impact Fakt\u00f6r:0.9<\/li>\n
      • A-2.;8 L. Kutlucan, A. Kutlucan, A. Ba\u015ft\u00fcrk, H. Kandi\u015f, H. Titiz, E. \u015eenocak, M. Da\u011fl\u0131, H. Ankaral\u0131. \u2018The effects of Anemia and Red Cell Transfusion on the Risk of Mortality Among Geriatric and Non-Geriatric Patients with Hospital-Acquired Infections in an \u0130ntensive Care Unit.\u2019 Turkish Journal of Geriatrics. 2015;18(2):104-109 \u0130mpact Fakt\u00f6r:0.130<\/li>\n
      • A-2;9; M. Dagli, A. Kutlucan, K. Fidan, L. Kutlucan, A. Basturk, SH. Ipekci. \u2018Diagnosis of the Combination of Immune Thrombocytopenia and Woodhouse-Sakati Syndrome.\u2019 American Journal of Medical Case Reports, 2016;4(3):108-110.<\/li>\n
      • A-2:10;A. Kutlucan, M. Dagl\u0131, L. Kutlucan, S. K\u0131r, A. Basturk, C. Ugurluoglu, H. Acar, M. Sozen, K. Turkay. \u2018A Case of RelapsedChronic Myeloid Leukemia Admitted with theComplaints of Paraplegia and UrinaryIncontinence.\u2019 American Journal of Medical Case Reports, 2016;4(4):126-129<\/li>\n
      • A-2.11;A. Kutlucan, M. Dagl\u0131, L. Kutlucan, A. Basturk. \u2018Neutropenia Due to Acute Exposure with Aluminium Phosphide.\u2019 Eur J Gen Med 2105;12(4):371.<\/li>\n
      • A-2.12;Y\u0131lmaz .A,Da\u011fl\u0131.M,Allahverdi.N Afuzzy expert system des\u0131ng for \u0131ron def\u0131c\u0131ency anem\u0131a (2013) 7th international conference application of information and communication Technologies\/AICT2013 (7) PP.456-459<\/li>\n
      • A-2.13;B.\u00d6zt\u00fcrk,H.Vatansev,A.Taner,M.Da\u011fl\u0131.A.\u00dcnl\u00fc ;Asymmetric Dimetylarginine Level in Beh\u00e7et Disease Turkish Journal of Biochemistry;2014;39(3):362-367. Impact fakt\u00f6r;0,703<\/li>\n
      • A-2.14;A. Kutlucan, M. Dagl\u0131, L. Kutlucan, S. K\u0131r, A. Basturk, C. Ugurluoglu, H. Acar, M. Sozen, K. Turkay. \u2018A Case of RelapsedChronic Myeloid Leukemia Admitted with theComplaints of Paraplegia and UrinaryIncontinence.\u2019 American Journal of Medical Case Reports, 2016;4(4):126-129<\/li>\n<\/ul>\n

        Publications in Other Internationally Refereed Journals<\/strong><\/p>\n

          \n
        • A-3.1; M.Da\u011fl\u0131, S.Y\u0131lmaz,A.Sivrikaya,G.\u00c7elik,H.Vatansev: \u2018\u2019The Role of Prohepcidin and Hepcidin in Anemia Associated with Systemic Lupus Erythematosus.\u2019\u2019 World Applied Sciences Journal. (ISI) , 2032-2036 pp., 2011<\/li>\n
        • A-3.2; M.Da\u011fl\u0131,A.Sivrikaya; Cancer and Thrombosis World Applied Sciences Journal(ISI) 2012;18;4;543-549<\/li>\n
        • A-3.3; M.Da\u011fl\u0131, A.\u0130hsan Ar\u0131k ;Malignant Lymphomas of the testis; Journal Urology 2010 ,1(3) 69-74 pp<\/li>\n
        • A-4; Uluslararas\u0131 j\u00fcrili \/ k\u00fcrat\u00f6rl\u00fc etkinliklere karma\/grup\/ki\u015fisel olarak kabul edilmek<\/li>\n
        • A-4.1;M.Da\u011fl\u0131; Uluslar aras\u0131 Avrasya Hematoloji kongresi; Temel hematoloji e\u011fitimi;Demir eksikli\u011fi anemisi ve tedavisi 08.10.2010<\/li>\n<\/ul>\n

          B- INTERNATIONAL PAPERS<\/strong><\/p>\n

          B-2.1) Those presented as posters in foreign languages \u200b\u200band whose abstracts are published<\/strong><\/p>\n

            \n
          • B-2.1.1<\/strong> ;Peripheral Blood stem cell (PBSC) collection with cylophosphomide (CY), etoposide and granulocyte colony st\u0131mulating factor. (6F) the effect of preleukopheresis circulating (PCL),CD 34 cell on the yield: T. Demirer, M. Ayl\u0131, M. G\u00fcnen, M. Arat, M. Da\u011fl\u0131<\/strong>\u00a0 .6.th Annual Meetign of the eurapeon Haematology Associotion 21-24 june 2001 Frankfurt Germany.<\/li>\n
          • B-2.1.2<\/strong> A.Randomised Study of comparasion of Leukophresis volumes\u00a0 8L verus 10L:\u00a0 T.Demirer, M. Ayl\u0131, N. G\u00fcnel\u00a0 A Demirer, M. Da\u011fl\u0131<\/strong>\u00a0 6.th Annual Meetign of the eurapeon Haematology 21-24-june 2001 Frankfurt Germany<\/li>\n
          • B-2.1.3;<\/strong> High dose thiotepe melphalan and carboplatin (TMCb) Fallowed by autologous stem cell transplation in patient wiht advanced breast cancer a retrospective evaluation: T.Demirer, M. Ayl\u0131, O. \u0130lhan, M. Da\u011fl\u0131<\/strong> . 29 th annuel meeting of the aeropan group for bood and Marrow transplantation.23-26 march 2003<\/li>\n
          • B-2.1.4<\/strong>; \u0130ncreased global fibronolyt\u0131c capacity in colorectal cancers. M.\u00d6zt\u011frk, N. \u015eeng\u00fcl, A.Ko\u015far, M Da\u011fl\u0131<\/strong>. 6.annual meeting of the european haematology association\u00a0 21-24 june 2001 Frankfurt Germany<\/li>\n
          • B-2.1.5;<\/strong> Phase II Study Of High-Dose Thiotepa Melphalan, and carbopilatin (TMCb) with autologous peripheral blood stem cell (PBSC) support in patients with hematologic malingnancies and solid tumors. T. Demirer , O. \u0130lhan, M. Ayl\u0131, M.Da\u011fl\u0131<\/strong> the 42 nd ASH annual meeting 13.08.2000<\/li>\n
          • B-2.1.6<\/strong>;Malingnant lympohomas of the testis. F.Berkmen, M. Da\u011fl\u0131<\/strong>, 7th Annuel winter oncolgy conference 17-19 December 2002<\/li>\n<\/ul>\n

            POST-ASSOCIATE PROFESSOR INTERNATIONAL PAPERS<\/strong><\/p>\n

              \n
            • B-2.1.7 M. Dagli<\/strong>, L. Kutlucan, A. Basturk, A. Kutlucan, B. Copur. Vth 2014 5International Eurasian Hematology Congress dahilinde “Poster” bildiri kitap\u00e7\u0131\u011f\u0131ndaki \u2018Comparison of pulse with high dose steroid treatment in patients with immun thrombocytopenia.\u2019 59 pp., Antalya, Turkey, October 2014<\/li>\n
            • B.2.1.8\u00a0 M. Dagli<\/strong>, A. Basturk, L. Kutlucan, B. Copur, A. Kutlucan, F. Sahin. Vth International Eurasian Hematology Congress dahilinde “Poster” bildiri kitap\u00e7\u0131\u011f\u0131ndaki \u2018Severe Renal Failured due to high dose Methotrexate in Acute Lymphoblastic Leukemia Associated with Predisposing Factors: Case Report.\u2019 52 pp., Antalya, Turkey, October 2014<\/li>\n
            • B.2.1.9<\/strong>;L. Kutlucan, A. Kutlucan, H. Kandis, H. Titiz, E. Senocak, A. Basturk, M. Dagl<\/strong>i, H. Ankaral\u0131, M. Geyik.Vth International Eurasian Hematology Congressdahilinde “Poster” bildiri kitap\u00e7\u0131\u011f\u0131ndaki \u2018The Effects of Anemia and Red Cell Transfusions on Mortality in Young and Elderly \u0130ntensive Care Patients with Nosocomial Infection.\u2019 51 pp., Antalya, Turkey, May\u0131s 2014<\/li>\n
            • B.2.1.10 ;<\/strong>A. Kutlucan, M. Dagl\u0131,<\/strong> L. Kutlucan, F. Ermis, A. Basturk, C. Ugurluoglu, M. Sozen. VIth International Eurasian Hematology Congress. \u2018Coincidence of Autoimmune Hemolytic Anemia and Autoimmune Hepatitis.\u2019 061 pp., Antalya Turkey. 14-18 October 2015.<\/li>\n
            • B-2.1.11 ; M. Dagl\u0131,<\/strong> A. Kutlucan, L. Kutlucan, A. Basturk, C. Ugurluoglu, M. Sozen, K. Turkay. VIth International Eurasian Hematology Congress. \u2018Blastic \u0130nfiltration of the Central Nervous System in a Patient with Chronic Myeloid Leukemia.\u2019 070 pp., Antalya Turkey. 14-18 October 2015<\/li>\n
            • B.2.1.12 ;M.Da\u011fl\u0131<\/strong>,A.Kutlucan.2015 ASH Congres\u2019Frequency Symptoms and Awareness of Anem\u0131a \u0131n Pregnant Voman\u2019\u2019p 74 Fa\u0131rmont Chicaco 18 September 2015<\/li>\n
            • B-2.1.13<\/strong> ;K. Fidan, A. Kutlucan, M. Dagl<\/strong>\u0131, A. Basturk, M. Sozen, S. Abusoglu, L. Kutlucan. VIth International Eurasian Hematology Congress. \u2018Chemotherapy \u0130mproved Coagulation Disorder in a Patient with Multiple Myeloma.\u2019 094 pp., Antalya Turkey. 14-18 October 2015<\/li>\n
            • B-.2.1.14; M. Da\u011fl\u0131,<\/strong> M. S\u00f6zen, L. Kutlucan, S. Abu\u015fo\u011flu, A. Kutlucan, A. \u00dcnl\u00fc, A. Ba\u015ft\u00fcrk. 13. Uluslararas\u0131 T\u00fcrkiye Hemofili Kongresi. \u2018Hemofili Hastalar\u0131nda D vitamini D\u00fczeyinin Sa\u011fl\u0131kl\u0131 Bireylerle Kar\u015f\u0131la\u015ft\u0131r\u0131lmas\u0131.\u2019 13pp., \u0130stanbul, T\u00fcrkiye. 17-19 Nisan 2016.<\/li>\n
            • B-2.1.15; M. Da\u011fl\u0131<\/strong>, L. Kutlucan, M. S\u00f6zen, A. Kutlucan, S. Abu\u015fo\u011flu, A. Ba\u015ft\u00fcrk, A. \u00dcnl\u00fc. 13. Uluslararas\u0131 T\u00fcrkiye Hemofili Kongresi. \u2018\u0130nflamasyon G\u00f6stergeleri olan Platelet Lenfosit Oran\u0131 ve N\u00f6trofil Lenfosit Oran\u0131n\u0131n, Hemofili Hastalar\u0131 ve Sa\u011fl\u0131kl\u0131 Bireylerle<\/li>\n
            • B-2.1.16 <\/strong>; MZ. Kocak, M. Dagli,<\/strong> A. Kutlucan, A. Basturk, A. Unlu, H. Acar, L. Kutlucan. 21. Congress of the European Hematology Association. PB2028., Copenhagen, Denmark June 9-12, 2016.<\/li>\n
            • B-2.1.17 ;<\/strong>A.Kutlucan,L.Kutlucan,A.Ba\u015ft\u00fcrk,M.Da\u011fl\u0131<\/strong>,G.Tra\u015f VII th International Eurasian Hematology Congress.\u2019Secondary Acute lympyhoblastik leucem\u0131a developed after Refractory Le\u0131omyosarcoma (2017) S60 \u0130stanbul;18-21 octaber 2017<\/li>\n
            • B-2.1.18 ;<\/strong> A.Kutlucan,M.Da\u011fl\u0131<\/strong>,L.Kutlucan,M.Kuku,A.Ba\u015ft\u00fcrk\u2019\u2019 VIIth International Eurasian Hematology Congress \u2018Paravertepral exramedullary Hematopo\u0131es\u0131s in pat\u0131ent with thlassem\u0131a \u0131ntermed\u0131a\u2019 S60 \u0130stanbul;18-21 octaber 2017<\/li>\n
            • B-2.1.19; M.Da\u011fl\u0131<\/strong>,A.Bast\u00fcrk,A.Kutlucan,L.Kutlucan; VIIth International Eurasian Hematology Congress.\u2019Thyrozine K\u0131nase \u0131nh\u0131b\u0131tors \u0131n central Neervous System Relapse of A Chron\u0131c Myelo\u0131d Leukem\u0131a:A Case Report\u2019 S60 \u0130stanbul;18-21 octaber 2017<\/li>\n
            • B-2.1.20; M.Da\u011fl\u0131<\/strong>,A.Kutlucan,S.Abusoglu,A.Bast\u00fcrk,M.S\u00f6zen,L.Kutlucan,A.\u00dcnl\u00fc,F.Y\u0131lmaz VIIth International Eurasian Hematology Congress.\u2019Evaluat\u0131on of Bone M\u0131neral Dens\u0131ty And Parameters Related to Bone Metabol\u0131sm In Hemoph\u0131l\u0131c Pat\u0131ent\u2019 S62 \u0130stanbul;18-21 octaber<\/li>\n
            • B-2.1.21;<\/strong>M.Z.Kocak,M.Da\u011fl\u0131,<\/strong>A.Kutlucan,A.Basturk,A.Unlu,H.Acar,L.Kutlucan VIIth International Eurasian Hematology Congress.\u2019\u2019cl\u0131n\u0131cal \u0131mportance of gl\u0131coprote\u0131n 1 ant\u0131bod\u0131es \u0131n bcr-abl negat\u0131ve myeloprol\u0131ferat\u0131ve neoplasms\u2019 S62 \u0130stanbul;18-21 octaber 2017<\/li>\n
            • B-2.1.22<\/strong>; R.Topkafa,ASivrikaya,S.Abu\u015fo\u011flu,MDa\u011fl\u0131,<\/strong>M.Topkafa\u2019\u2019Lipid levels in patient vith Mult\u0131pl Myeloma\u2019\u201915 Euro fed l\u0131p\u0131d Congress 27-30 august 2017 Uppsala \u2013Sweden<\/li>\n
            • B-2.1.23;<\/strong> E.Menev\u015fe,A.Sivrikaya,M.Tok,.MDa\u011fl\u0131,<\/strong>F.Z.Erbayram\u2019\u2019Association Betveen Mean Platelet Volume Level and Non-Hodgkin lynfoma;KlinikBiyokimya Uzmanlar\u0131 Derne\u011fi;Uluslar aras\u0131kat\u0131l\u0131ml\u0131 kongreLapxExpo 1-5 Ekim 2017<\/li>\n
            • B-2.1.24<\/strong>;E.Menev\u015fe,M.Tok.M.Da\u011fl\u0131.<\/strong>A.Sivrikaya\u2019\u2019Retrospective Observatial Study:Mean Platelet volume and neutrophil to lymphocyte Rat\u0131o in secondary Polycytem\u0131a\u2019\u2019 Internat\u0131onal Academ\u0131k Researc Congress :INES201<\/li>\n<\/ul>\n

              D-ULUSAL \u00c7ALI\u015eMALAR<\/strong><\/p>\n

              D-1. Ulusal hakemli dergilerde yay\u0131nlanan ara\u015ft\u0131rma makalesi:<\/strong><\/p>\n

                \n
              • D-1.1;<\/strong> . M. Da\u011fl\u0131, <\/strong>M.Ayl\u0131, S.Y\u0131lmaz;<\/strong> 0 kan grubunda\u00a0 agglutinasyon Titraji ve Klinik \u00f6nemi. Acta Oncologica Turcica<\/strong>. 1995.28:3-4 .<\/li>\n
              • D-1.2.<\/strong> S. \u00d6zkan ,M.Da\u011fl\u0131 \u2018<\/strong>\u2019Staf\u0131lokokkal Protein A ve Endotoksin kombinasyonunun Kanserli Hastalarda NK ve LAK H\u00fccreleri \u00dczerine Etkisi\u2019\u2019<\/strong> T\u00fcrkiye T\u0131p Derne\u011fi <\/strong>1998;5(4) 227-234.<\/li>\n
              • D-1.3;<\/strong> M. Tuz, M. Da\u011fl\u0131<\/strong>, M.Turanl\u0131;\u2019\u2019 Trombositopeniye ba\u011fl\u0131 burun kanamas\u0131nda Gelfoma Tampon ve Klasik Ekstrafor\u00a0\u00a0 Tampon uygulamas\u0131.\u2019 Kulak burun bo\u011faz ihtisas dergisi <\/strong>2000(3);200-204.<\/li>\n
              • D-1.4<\/strong>; H.G\u00f6kmen Soysal, M.Da\u011fl\u0131;<\/strong> \u2018\u2019Yeti\u015fkin L\u00f6semi Hastalar\u0131nda Oftalmolojik Bulgular\u2019\u2019 T\u00fcrk Oftalmaloji Gazetesi<\/strong> 2002 (32 ) 6.<\/li>\n
              • D-1-5;<\/strong> S.Ayaz,M. Da\u011fl\u0131,;<\/strong> Kardiyak operasyonlarda aptotinin kullan\u0131m\u0131n\u0131n kanama \u00fczerindeki etkisi: Klinik bilimler ve doktor <\/strong>2003 (3) 260-263.<\/li>\n
              • D-1.6;<\/strong> Ba\u015ft\u00fcrk, L. Kutlucan, A. Kutlucan, A. Tazeg\u00fcl Pekin, S. Ak\u0131nc\u0131, M. Da\u011fl\u0131,<\/strong> S. Din\u00e7er. \u2018Gebelerdeki Anemi Fark\u0131ndal\u0131\u011f\u0131 ve Anemi Geli\u015fimine Etkili Fakt\u00f6rlerin De\u011ferlendirilmesi\u2019. Eur J Health Sci 2016;2(1):1-4<\/li>\n
              • D-1.7; D-11<\/strong>; Biochemical Markers in Welding Exposure S. Abusoglu, *a A. Unlu, a A. Sivrikaya, a M. Dagli, b E. Tutkun,c H. Vatanseva and B. Ozturka Accepted 3 th May 2013 International Journal of Mevlana Medical Sciences<\/li>\n<\/ul>\n

                D-1.1. Reviews, case reports, technical notes, short articles, book or article analyses, letters to the editor and discussions published in national refereed journals:<\/strong><\/p>\n

                  \n
                • D-1.1.1.<\/strong> H.Bodur, H.\u00d6zdemir, M.Da\u011fl\u0131<\/strong>, ;<\/strong> Klippel-feil sendromu Romatol\u00a0\u00a0 Fib.Rehab<\/strong>.1991;2(2):111-113.<\/li>\n
                • D-1.1.2;<\/strong> K. Yama\u00e7, F. T\u00f6r\u00fcner, M. Da\u011fl\u0131<\/strong>: Vir\u00fcsler ve Kanser;<\/strong> Prognoz<\/strong>. 1997; 1(3):29-32 .<\/li>\n
                • D-1.1.3;<\/strong> A. Ko\u015far, M. Da\u011fl\u0131<\/strong>.; \u00a0Anemisi olan hastaya yakla\u015f\u0131m Pratik Noktalar; . \u0130\u00e7 Hasta-l\u0131klar progres 2000,1,(7);201-215<\/li>\n
                • D-1.1.4;<\/strong> Dr. M. Da\u011fl\u0131 , <\/strong>Dr.\u015e. Yenice, Dr. S. Y\u0131lmaz \u2018\u2019Gaucher hastal\u0131\u011f\u0131\u2019\u2019 Klinik Bilimler ve Doktor <\/strong>Kas\u0131m 2002;8(6)697-700<\/li>\n<\/ul>\n

                  D-2 To be accepted to national juried\/curated events as a mixed\/group\/individual<\/strong><\/p>\n

                    \n
                  • D-2.1.M.Da\u011fl\u0131 9th Turkish Hemophilia Congress; Hemophilia hematology specialist relationship.1704.2012<\/li>\n
                  • D-3) To be accepted to national events as mixed\/group\/individual<\/li>\n<\/ul>\n

                    E-NATIONAL NOTIFICATIONS<\/strong><\/p>\n

                    E-1.1;Oral presentations and published summaries<\/strong><\/p>\n

                      \n
                    • E-1.1.1-.M.Da\u011fl\u0131,<\/strong> K\u0131rm\u0131z\u0131 H\u00fccre Fizyolojisi konferans\u0131 dahilinde “Ulusal Hematoloji Kongresi s\u00f6zl\u00fc sunu” bildiri kitap\u00e7\u0131\u011f\u0131ndaki “Ankilozan Spondilit Hastalar\u0131nda g\u00f6r\u00fclen Anemide Prohepsidin ve Hepsidinin rol\u00fc”, 34-35 pp., Antalya,T\u00fcrkiye, Ekim 2010<\/li>\n
                    • E-1.1.2-.<\/strong>S.Y\u0131lmaz,A.Sivrikaya,H.Vtatansev,M.Da\u011fl\u0131<\/strong>, Ulusal Biyokimya Kongresi konferans\u0131 dahilinde “T\u00fcrk Biyokimya Dergisi” bildiri kitap\u00e7\u0131\u011f\u0131ndaki “Beh\u00e7et Hastalar\u0131nda Serum Arginin ve Arginin T\u00fcrev D\u00fczeyleri”, 32 pp., Eski\u015fehir,T\u00fcrkiye, Ekim 2010<\/li>\n
                    • E-1.1.3-.<\/strong>A.Sivrikaya,B.\u00d6zt\u00fcrk,S.Y\u0131lmaz,M.Da\u011fl\u0131<\/strong>, Ulusal Biyokimya Kongresi konferans\u0131 dahilinde “T\u00fcrk Biyokimya Dergisi” bildiri kitap\u00e7\u0131\u011f\u0131ndaki “Ankilozan Spondilit Hastalar\u0131nda Serum ADMA,Arginin ,Sitrulin Seviyeleri”, 37 pp., Eski\u015fehir,T\u00fcrkiye, Ekim 2010<\/li>\n
                    • E-1.1.4-.<\/strong>A.Sivrikaya,B.\u00d6zt\u00fcrk,S.Y\u0131lmaz,M.Da\u011fl\u0131, <\/strong>Ulusal Biyokimya Kongresi konferans\u0131 dahilinde “T\u00fcrk Biyokimya Dergisi” bildiri kitap\u00e7\u0131\u011f\u0131ndaki “Ankilozan Spondilit Hastalar\u0131nda Serum ADMA,Arginin ,Sitrulin Seviyeleri”, 37 pp., Eski\u015fehir,T\u00fcrkiye, Ekim 2010<\/li>\n<\/ul>\n

                      E-2.1) Those presented as posters and whose abstracts were published<\/strong><\/p>\n

                        \n
                      • E-2.1.1:<\/strong>T\u00fcrkiyede\u00a0 hodgkin hastal\u0131\u011f\u0131 Ebstein-Barr Vir\u00fcs LP-1 . K.Yama\u00e7, O.Suer, T. Fen, Z.Ak\u0131, M.Da\u011fl\u0131<\/strong> XXVI\u00a0 Ulusal Hematoloji kongresi 1998,31 ekim -3 kas\u0131m.<\/li>\n
                      • E-2.1.2<\/strong>:Mide musin\u00f6z adenokarsinomu Kemik ili\u011fi tutulumu\u00a0 M.Da\u011fl\u0131<\/strong>, XIII Ulusal kanser kongresi 27 nisan -1 may\u0131s 1999.<\/li>\n
                      • E-2.1.3:<\/strong>Gastrointestinal lenfomalar cerahi tedavisi. S.Kutun, M. Da\u011fl\u0131<\/strong> XIII Ulusal kanser kongresi 1999 27 nisan-1 may\u0131s.<\/li>\n
                      • E-2.1.4-<\/strong>A.Onkoloji Hastanesi primer Gastrointestinal lenfoma olgular\u0131.N.Alk\u0131\u015f,M Da\u011fl\u0131<\/strong> . XIII Ulusal kanser kongresi 1999\u00a0 27 Nisan-1 May\u0131s.<\/li>\n
                      • E.2.1.5-<\/strong>Testik\u00fcler Maling Lenfoma.F.Berkmen,M Da\u011fl\u0131<\/strong> XXVI Ulusal Hematoloji kongresi\u00a0\u00a0\u00a0\u00a0\u00a0 2001;11-13 Kas\u0131m.<\/li>\n
                      • E-2.1.6<\/strong>-Primer Kemik Lenfomas\u0131. M. Da\u011fl\u0131.<\/strong> XXXII Ulusal Hematoloji Kongresi ve IV Mezuniyet Sonras\u0131 E\u011fitim Kursu. 1999, 10-11 Kas\u0131m.<\/li>\n
                      • E-2.1.7-<\/strong>Non Hodking Lenfomalarda\u00a0 CEOP Tedavisi \u00d6n Sonu\u00e7lar M. Da\u011fl\u0131<\/strong>, A. Helvac\u0131o\u011flu. XXVII Ulusal Hematoloji Kongresi, Hematoloji 1. Basamak Kursu V. Mezuniyet Sonras\u0131 Hematoloji\u00a0 kursu 2000 1-4 Kas\u0131m.<\/li>\n
                      • E-2.1.8-<\/strong>Akut Lenfoblastik L\u00f6semide\u00a0 Deneyimlerimiz. M. Da\u011fl\u0131.<\/strong> XXVII Ulusal\u00a0\u00a0 Hematoloji Kongresi Hematoloji\u00a0\u00a0 1. Basamak Kursu V. Mezuniyet Sonras\u0131 Hematoloji\u00a0 kursu 2000 1-4 Kas\u0131m.<\/li>\n
                      • E-2.1.9-<\/strong>Non\u00a0 Hodgkin Lenfoma Serum Ca 125 De\u011ferleri. M. Da\u011fl\u0131.<\/strong> XXVII Ulusal\u00a0\u00a0 Hematoloji Kongresi Hematoloji\u00a0\u00a0 1. Basamak Kursu\u00a0 ve\u00a0 Mezuniyet Sonras\u0131 Mezuniyet Kursu 2000. 1-4 Kas\u0131m.<\/li>\n
                      • E-2.1.10<\/strong>-Cerebral Klorama. M. Da\u011fl\u0131<\/strong>, F. Marko\u00e7,\u00a0 XXVII\u00a0 Ulusal\u00a0\u00a0 Hematoloji Kongresi Hematoloji 1. Basamak Kursu Mezuniyet Sonras\u0131 Mezuniyet\u00a0 kursu 2000 1-4 Kas\u0131m puan;1.4<\/li>\n
                      • E-2.1.11<\/strong>-Multipl\u00a0 Myelomal\u0131 ya\u015f fakt\u00f6r\u00fcn\u00fcn Prognostik \u00f6nemi M. Da\u011fl\u0131.<\/strong> Ulusal Kanser Kongresi 3 Nisan -4 May\u0131s 2001.<\/li>\n
                      • E-2.1.12<\/strong>-Multipl Myelomal\u0131 Olgular\u0131m\u0131z. M. Da\u011fl\u0131<\/strong> Ulusal Kanser Kongresi 3 Nisan -4 May\u0131s 2004.<\/li>\n
                      • E-2.1.13-<\/strong>Kemik ili\u011fi yetmezli\u011fi sendromunda allogenetik periferik k\u00f6k h\u00fccre\u00a0 tansplantasyonu. Ankara Numun Hastanesi Kemik ili\u011fi nakli merkezi deneyimi. \u00d6.\u00c7. \u00d6zdel, S. Din\u00e7er, Z. \u00c7elik, M. Da\u011fl\u0131<\/strong>. XXX Ulusal Mematoloji Kongresi 10-14 Ekim 2003.<\/li>\n
                      • E-2.1.14-<\/strong>8 litre ve 10 litre vakumlu lokoforezin\u00a0 rondomize kar\u015f\u0131la\u015ft\u0131r\u0131lmas\u0131. T. Demirel, M. Ayl\u0131, N. G\u00fcrel, M. Da\u011fl\u0131.<\/strong> XIX Gevher Nesibe\u00a0 t\u0131p g\u00fcnleri\u00a0 kongre ve Woskshop. Hematoloji Onkoloji G\u00fcncel yakla\u015f\u0131mlar ve Deneysel T\u00fcm\u00f6r Y\u00f6ntemleri 24-26 May\u0131s 2001.<\/li>\n
                      • E-2.1.15-<\/strong>Ankara Numune Hastanesi Allogenik K\u00f6k H\u00fccre Trnsplatasyonu T. Demirel, M. Ayl\u0131. R.Haznedar, T. Fen. M. Da\u011fl\u0131.<\/strong> XIX. Gevher\u00a0 Nesibe\u00a0 t\u0131p g\u00fcnleri\u00a0 kongre ve Woskshop 24-26 May\u0131s 2001.<\/li>\n
                      • E-2.1.16<\/strong>-Multipl Myelomda y\u00fcksek doz Melphalan ve otolo\u011f periferik\u00a0 k\u00f6k h\u00fccre tansplantasyonu.(Ankara Numune\u00a0 E\u011fitim ve Ara\u015ft\u0131rma Hastanesi Tecr\u00fcbesi) T.Demirel, M. Ayl\u0131, R. Haznedar, M. Da\u011fl\u0131.<\/strong> XIX. Gevher\u00a0 Nesibe\u00a0 t\u0131p g\u00fcnleri\u00a0 kongre ve Woskshop 24-26 May\u0131s 2001.<\/li>\n
                      • E-2.1.17<\/strong>-Lenfoma olgular\u0131yla y\u00fcksek doz Thotepa, Melphalon carboplatin (TMCB9 sonras\u0131 otolo\u011f\u00a0 k\u00f6k h\u00fccre nakli. T. Demirer, E. Soydan, M. Ayl\u0131,<\/strong>\u00a0 M. Da\u011fl\u0131\u00a0\u00a0 XXX. Ulusal Hematoloji Kongresi 10-14 Ekim 2003.<\/li>\n
                      • E-2.1.18<\/strong>–M.Da\u011fl\u0131<\/strong>, Temel Hematoloji E\u011fitimi konferans\u0131 dahilinde “Avrasya Hematoloji Kongresi” bildiri kitap\u00e7\u0131\u011f\u0131ndaki “Demir eksikli\u011fi Anemisi ve Tedavi”, 179-180 pp., Antalya ,T\u00fcrkiye, Ekim 2010.<\/li>\n
                      • E-2.1.19-.<\/strong>H.Vatansev,A.K\u0131y\u0131c\u0131,S.Y\u0131lmaz,M.Da\u011fl\u0131<\/strong>, Ulusal Biyokimya Kongresi konferans\u0131 dahilinde “T\u00fcrk Biyokimya Dergisi” bildiri kitap\u00e7\u0131\u011f\u0131ndaki “Romatoid Artridli Hastalarda Arginin ve Asimetrik Dimetil Arginin D\u00fczeyleri”, 39 pp., Eski\u015fehir,T\u00fcrkiye, Ekim 2010<\/li>\n
                      • E-2.1.20<\/strong>-H.Vatansev,A.Taner,S.Y\u0131lmaz,M.Da\u011fl\u0131,<\/strong> Ulusal Klinik Biyokimya Kongresi konferans\u0131 dahilinde “T\u00fcrk Biyokimya Dergisi” bildiri kitap\u00e7\u0131\u011f\u0131ndaki “SLE hastalar\u0131nda Serum Arjinin adma,sitrulin D\u00fczeyleri,Adma\/Arjinin oranlar\u0131.”, 40 pp., Antalya,T\u00fcrkiye, May\u0131s 2011.<\/li>\n
                      • E-2.1.21<\/strong>–M.Da\u011fl\u0131<\/strong>,S.Y\u0131lmaz., Ulusal \u0130\u00e7 Hastal\u0131klar\u0131 Kongresi konferans\u0131 dahilinde “\u0130\u00e7 Hastal\u0131klar\u0131 kongre kitab\u0131” bildiri kitap\u00e7\u0131\u011f\u0131ndaki “Beh\u00e7et Hastal\u0131\u011f\u0131 ile ili\u015fkili Anemide Prohepsidin ve Hepsidinin Rol\u00fc”, 76 pp., Antalya,T\u00fcrkiye, Ekim 2011.<\/li>\n
                      • E-2.1.22<\/strong>-H.Korkmaz,S.E\u015fmen,S.Y\u0131lmaz,M.Da\u011fl\u0131<\/strong>;otoimmunhepatit,bilier siroz(overlap senromu), veotoimmun anemi,idiopatik trombositopenik purpura(evans sendromu)birlikteli\u011fi; 9.UlusalHepatogastroentoroloji Kongresi 26-30 eyl\u00fcl 2012 K\u0131br\u0131s.<\/li>\n
                      • E-2.1.23 ;<\/strong>S.E\u015fmen,L.Kebabc\u0131lar,M.Da\u011fl\u0131<\/strong>,A.Topcu,S.Y\u0131lmaz;Adrenal hematom ve periferik arteryel tromboz ile ba\u015fvuran antifosfalipid sendromu olgusu;13 ulusal romatoloji kongresi 13-17 ekim2012.<\/li>\n<\/ul>\n

                        POST-ASSOCIATE PROFESSORSHIP<\/strong><\/p>\n

                          \n
                        • E-2.1.24;M. Da\u011fl\u0131,<\/strong> E. \u00d6zt\u00fcrk, M. S\u00f6zen, A. Kutlucan, F. \u00c7\u00f6lkesen. 5. Ulusal Lenfoma-Miyeloma Kongresi. \u2018Subkonjunktival Kanamayla Ba\u015fvuran Normal Sedimantasyon D\u00fczeyli Bruselloz Olgusu.\u2019 Antalya, T\u00fcrkiye, Nisan 2014.<\/li>\n
                        • E-2.1.25; M. Da\u011fl\u0131,<\/strong> M. S\u00f6zen, E. \u00d6zt\u00fcrk, A. Kutlucan, \u0130C. Kendir. 5. Ulusal Lenfoma-Miyeloma Kongresi. \u2018Kolestaz Bulgusu Olmadan Drekt Hiperbilir\u00fcbinemi ve Diren\u00e7li Ate\u015fle Seyreden NonHodgkin Lenfoma Olgusu.\u2019 Antalya, T\u00fcrkiye, Nisan 2014.<\/li>\n
                        • E-2.1.26<\/strong>;F. \u015eahin, A. Kutlucan, M. Da\u011fl\u0131<\/strong>, L. Kutlucan. Deneysel Hematoloji Kongresi. \u2018Kronik Miyelositer L\u00f6semi Hastas\u0131nda Dasatinibe Ba\u011fl\u0131 Transuda \u00d6zelli\u011finde Ef\u00fczyon.\u2019 44 pp., Kayseri, T\u00fcrkiye. 17-19 Nisan 2015<\/li>\n
                        • E-2.1.27; M. Da\u011fl\u0131<\/strong>, A. Kutlucan. 12. Ulusal Hemofili Kongresi. \u2018Hemofili v etoplum sa\u011fl\u0131\u011f\u0131p\u201d.\u2019Antalya, T\u00fcrkiye. 16-19 Nisan 2015.<\/li>\n
                        • E-2.1.28<\/strong>; Elverdi, M. Da\u011fl\u0131<\/strong>, L. Kutlucan, A. Kutlucan, A. Ba\u015ft\u00fcrk. Uluslararas\u0131 Kat\u0131l\u0131ml\u0131 Deneysel Hematoloji Kongresi. Diren\u00e7li Multipl Miyelom Olgusunda, Nadir G\u00f6r\u00fclen Sekonder\u00a0 OrganT\u00fcm\u00f6r\u00fc.Kayseri,T\u00fcrkiye.5-8May\u0131s 2016<\/li>\n
                        • E-2.1.29<\/strong>; A. Elverdi, M. Da\u011fl\u0131,<\/strong> L. Kutlucan, A. Kutlucan, A. Ba\u015ft\u00fcrk, A. Ceylan. 1. Hematolojik \u0130mm\u00fcnoloji Kongresi. \u2018Otoimm\u00fcn \u0130nflamatuar Hastal\u0131\u011fa Sekonder Geli\u015fen Diff\u00fcz B\u00fcy\u00fck B H\u00fccreli Lenfoma.\u2019 KKTC, 24-27 Mart 2016.<\/li>\n
                        • E-2.1.30;<\/strong> A. Kutlucan, M. Da\u011fl\u0131,<\/strong> A. Ba\u015ft\u00fcrk, M. Ayaz, A. Sivrikaya. Semptom ve Bulgu Olmaks\u0131z\u0131n Bilir\u00fcbin ve Laktat Dehidrogenez\u0131n Belirgin Y\u00fcksekdi\u011fi Multipl Miyelom Olgusu. 42. Ulusal Hematoloji Kongresi. Antalya, T\u00fcrkiye. 19-22 Ekim 2016<\/li>\n
                        • E-2.1.31;<\/strong> S.Y\u0131lmaz,S.E\u015fg\u00fcl\u00fc,M.Da\u011fl\u0131<\/strong> 4 Ulusal vakalar ile romatoloji E\u011fitimi Sempozyumu; Mak\u00fclapap\u00fcler D\u00f6k\u00fcnt\u00fc Ate\u015f ve kilo kayb\u0131 ile ba\u015fvuran olgu\u2019\u201913-14 Mart2014 Trabzon<\/li>\n
                        • E-2.1.32<\/strong>;S.E\u015fg\u00fcl\u00fc,S.Y\u0131lmaz.M.Da\u011fl\u0131<\/strong>,E.Din\u00e7t\u00fcrk;Romatolojide Son 2 y\u0131l\u2019\u2019Sj\u00f6gren Sendromu ve Monoklonal Gamapati:olgu sunumu\u2019\u201910-13 nisan2014 izmir.<\/li>\n
                        • E-2.1.33 ; M. Da\u011fl\u0131,<\/strong> A. Kutlucan, S. Abu\u015fo\u011flu, A. Ba\u015ft\u00fcrk, M. S\u00f6zen, L. Kutlucan, A. \u00dcnl\u00fc. T\u00fcrkiye Hemofili Kongresi\u2019\u2019Hemofili Hastalar\u0131nda Kemik Y\u0131k\u0131m Markeri Olan \u0130drar N-terminal Telopeptit\/Kreatinin Oran\u0131n\u0131n De\u011ferlendirilmesi. Antalya, 12-15 Nisan 2017.<\/li>\n
                        • E-.2.1.34; M. Da\u011fl\u0131,<\/strong> A. Kutlucan, S. Abu\u015fo\u011flu, A. Ba\u015ft\u00fcrk, M. S\u00f6zen, L. Kutlucan, A. \u00dcnl\u00fc. T\u00fcrkiye Hemofili Kongres Hemofili Hastalar\u0131nda Serum Prokollojen D\u00fczeyleri. Antalya, 12-15 Nisan 2017.<\/li>\n
                        • E-2.1.35;<\/strong> M. \u00c7orumlu, A. Ba\u015ft\u00fcrk, M. Da\u011fl\u0131,<\/strong> A. Kutlucan, AM. \u00d6zek. Sekonder Enfeksiyonla Komplike Olan Akrodermatitis Enteropatika Olgusu.Selim Hematoloji\u00a0 Antalya, 24-26 \u015eubat 2017.<\/li>\n
                        • E-2.1.36;<\/strong> SF Oktar, A. Kutlucan, M. Da\u011fl\u0131,<\/strong> NA. Demir, A. Ba\u015ft\u00fcrk. Azatiopirinin Yol A\u00e7t\u0131\u011f\u0131 Pseudol\u00f6semi. 2 Ulusal Kan ve Kemik ili\u011fi kongresi KKTC, 16-19 \u015eubat 2017<\/li>\n
                        • E-2.1.37; M. Da\u011fl\u0131,<\/strong> A. Kutlucan, A. Ba\u015ft\u00fcrk, H. Durmu\u015f, S. \u00c7elik, M. \u00c7orumlu. Eri\u015fkin Ya\u015fta Tan\u0131 Konulan \u2018Tiamin Responsiv Megaloblastik Anemi Sendromu\u2019 Olgusu. Antalya, 24-26 \u015eubat 2017<\/li>\n
                        • E.2.1.38; M.Da\u011fl\u0131<\/strong>,M.S\u00f6zen,L.Kutlucan,S.Abu\u015fo\u011flu,,A.Kutlucan,A.Ba\u015ft\u00fcrk T\u00fcrkiye hemofili kongresi\u2019\u2019Hemofili hastalar\u0131nda D Vitamini D\u00fczeyinin Sa\u011fl\u0131kl\u0131 Bireylerle Kar\u015f\u0131la\u015ft\u0131r\u0131lmas\u0131\u00a0 17-19 nisan \u0130stanbul<\/li>\n
                        • E-2.1.39;M.Da\u011fl\u0131<\/strong>,M.S\u00f6zen,L.Kutlucan,S.Abu\u015fo\u011flu,,A.Kutlucan,A.Ba\u015ft\u00fcrk\u2019\u2019\u0130nflamasyon G\u00f6stergeleri olan platelet lenfosit oran\u0131 ve N\u00f6trofil lenfosit Oran\u0131n\u0131n Hemofili Hastalar\u0131 ve Sa\u011fl\u0131kl\u0131 Bireylerle Kar\u015f\u0131la\u015ft\u0131r\u0131lmas\u0131\u2019\u2019T\u00fcrkiye Hemofili Kongresi 17-19 Nisan 2016 \u0130stanbul<\/li>\n
                        • E-2.1.40;<\/strong>A.Kutlucan,K.Fidan,M.Da\u011fl\u0131<\/strong>,A.Ba\u015ft\u00fcrk;\u0130mmun Trombositopeni ve woodhause-sakati syndrome Birlikteli\u011fi;P 093 41 Ulusal hematoloji Kongresi21-24 Ekim 2015 Antalya<\/li>\n
                        • E2.1.41<\/strong>;A.Ba\u015ft\u00fcrk,A.Kutlucan,M.Da\u011fl\u0131<\/strong>,G.Kocamaz,S.Abu\u015fo\u011flu,S.U\u011fra\u015f,N.A.Demir\u2019M.MyelomdanLe\u0131 hmania ya yolculuk\u2019\u20194.Hematolojik Onkoloji Kongresi K.K.T.C16-17 Eyl\u00fcl 2017<\/li>\n
                        • E-2.1.42; M.Da\u011fl\u0131<\/strong>,A.Ba\u015ft\u00fcrk,A.Kutlucan\u2019\u2019Vitamin B12 eksikli\u011fi ile presente olan PNH olgusu \u2019\u20194.Hematolojik Onkoloji Kongresi K.K.T.C16-17 Eyl\u00fcl 2017.<\/li>\n
                        • E.2.1.43;<\/strong> A.Ba\u015ft\u00fcrk,M.Da\u011fl\u0131<\/strong>,A.Kutlucan,A.Elverdi\u2019\u2019mult\u0131pl myelom vakas\u0131nda kemoterapiye ba\u011fl\u0131 beklenti konv\u00fclsiyonu\u2019\u201943.ulusal Hematoloji Kongresi,1-4 Kas\u0131m2017 Antalya<\/li>\n
                        • E-2.1.44;<\/strong> A.Kutlucan,M.Da\u011fl\u0131<\/strong>,L.Kutlucan,A.Ba\u015ft\u00fcrk;\u2019\u2019Santral sinir sistemi tutulumu sonras\u0131 kullan\u0131lan Dasatinip veNilotinibin ciddi yan etkilerinin geli\u015fti\u011fi nadir olgu \u2019\u2019P-157 43.ulusal Hematoloji Kongresi,1-4 Kas\u0131m2017 Antalya<\/li>\n
                        • E-2.1.45<\/strong>;M.Z.Ko\u00e7ak,M.Da\u011fl\u0131<\/strong>\u2019\u2019ET ve PV Hastalar\u0131nda platelet\/lenfosit oran\u0131 n\u00f6trofil\/lenfosit ve baz\u0131 hemogram parametrelerinin tromboz ile ili\u015fkisi\u2019\u2019P-149 43.ulusal Hematoloji Kongresi,1-4 Kas\u0131m2017 Antalya<\/li>\n
                        • E-2.1.46;M.Da\u011fl\u0131<\/strong>,A.Kutlucan,L.Kutlucan,A.Ba\u015ft\u00fcrk,G.Tra\u015f;Refrakter Leiomyosarkom Hastas\u0131nda sekonder ortaya \u00e7\u0131kan akut lenfoblastik l\u00f6semi olgusu\u2019\u2019P-192 43.ulusal Hematoloji Kongresi,1-4 Kas\u0131m2017 Antalya<\/li>\n
                        • E-2.1.47<\/strong>;A.Kutlucan,A.Pekin,M.Da\u011fl\u0131<\/strong>,A.Ba\u015ft\u00fcrk\u2019\u2019Hamile kad\u0131nlarda anemi s\u0131kl\u0131\u011f\u0131n\u0131n,semptomlar\u0131n\u0131n ve fark\u0131ndal\u0131\u011f\u0131n\u0131n de\u011ferlendirilmesi;41 ulusal hematoloji kongresi<\/li>\n<\/ul>\n

                          [\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"

                          N\u00f6roloji <\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[4,1380],"tags":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/medova.com.tr\/en\/wp-json\/wp\/v2\/posts\/4881"}],"collection":[{"href":"https:\/\/medova.com.tr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medova.com.tr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medova.com.tr\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/medova.com.tr\/en\/wp-json\/wp\/v2\/comments?post=4881"}],"version-history":[{"count":1,"href":"https:\/\/medova.com.tr\/en\/wp-json\/wp\/v2\/posts\/4881\/revisions"}],"predecessor-version":[{"id":4882,"href":"https:\/\/medova.com.tr\/en\/wp-json\/wp\/v2\/posts\/4881\/revisions\/4882"}],"wp:attachment":[{"href":"https:\/\/medova.com.tr\/en\/wp-json\/wp\/v2\/media?parent=4881"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medova.com.tr\/en\/wp-json\/wp\/v2\/categories?post=4881"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medova.com.tr\/en\/wp-json\/wp\/v2\/tags?post=4881"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}